HRTX
HERON THERAPEUTICS, INC. /DE/
Nasdaq Pharmaceutical Preparations Accelerated filer

Key Financials

Net Income
$-20195000
↓ 48.7%
Gross Profit
$113.6M
↑ 7.5%
Operating Income
$-2538000
↑ 78.0%
Total Liabilities
$241.5M
↓ 9.5%
EPS (Diluted)
$-0.12
↓ 33.3%
Cash & Equivalents
$28.6M
↑ 11.0%
Total Assets
$255.9M
↑ 9.7%
Shareholders' Equity
$14.3M
↑ 142.6%

Recent SEC Filings

Form Type Filed Date Link
8-K 6/16/2026 View on SEC
4 6/8/2026 View on SEC
8-K 6/2/2026 View on SEC
SCHEDULE 13G/A 5/13/2026 View on SEC
10-Q 5/11/2026 View on SEC
8-K 5/11/2026 View on SEC
4 5/7/2026 View on SEC
4 5/4/2026 View on SEC
4 5/4/2026 View on SEC
4 5/4/2026 View on SEC

Company Information

Field Value
Ticker HRTX
Company Name HERON THERAPEUTICS, INC. /DE/
CIK 818033
Sector Pharmaceutical Preparations
Industry Accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 8582514400